世界初の経口バイオ医薬リベルサス®（GLP-1受容体作動薬セマグルチド）

Related materials as well as pre- and post-revision versions

Detailed bibliographic record

Summary, etc.：: GLP-1受容体作動薬は，抗糖尿病作用に加え，多様な生理活性を有し，その重要性がますます高まっている．近年，作用時間の延長を目的とした分子の化学修飾が進められ，超持効性の薬物動態を持つアナログであるセマグルチドが開発された．さらに，セマグルチドは注射剤だけでなく，経口製剤であるリベルサス<su...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

J-STAGE
Digital
J-STAGE
CiNii Research
Search Service
Digital
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: 世界初の経口バイオ医薬リベルサス®（GLP-1受容体作動薬セマグルチド）
Author Heading: 武田真莉子
Publication Date: 2025
Publication Date (W3CDTF): 2025
Periodical title: 薬局薬学
No. or year of volume/issue: advpub 0
Volume: advpub
Issue: 0
Publication date of volume/issue (W3CDTF): 2025
ISSN (Periodical Title): 18843077
Publication (Periodical Title): Pharmacy Society of Japan
Text Language Code: ja
Subject Heading: バイオ医薬
GLP-1受容体作動薬
経口製剤
吸収促進剤
SNAC
Target Audience: 一般
DOI: 10.32160/yakkyoku.ra.2025-1000
Is Version Of: 1
Data Provider (Database): 国立情報学研究所 : CiNii Research
https://cir.nii.ac.jp/
Original Data Provider (Database): Japan Link Center
https://japanlinkcenter.org/top